1836 U.S. Patent Office fire

DeepTarget Granted Patent for Groundbreaking Digital Experience Platform and 3D Storyteller Technology

Tuesday, October 26, 2021 - 2:00pm

11,157,966 for its Digital Experience Platform (DXP) including 3D StoryTeller , related to uniquely engaging digital banking consumers at scale.

Key Points: 
  • 11,157,966 for its Digital Experience Platform (DXP) including 3D StoryTeller , related to uniquely engaging digital banking consumers at scale.
  • When DeepTarget DXP is combined with the transformative, socially-inspired 3D Storyteller, marketers turn raw data into engaging and personalized user experiences in real time.
  • This patent strengthens DeepTargets position at the forefront of digital marketing innovation, said Preetha Pulusani, CEO of DeepTarget.
  • DeepTarget provides a single Digital Experience Platform for financial institutions to manage the complete engagement-to-results lifecycle across all digital channels, resulting in increased revenue, loyalty and trust and decreased costs.

ionir Extends Support for CI/CD Pipeline Acceleration

Tuesday, October 26, 2021 - 1:03pm

NEW YORK, Oct. 26, 2021 /PRNewswire/ --ionir, a leader in Kubernetes Data Services, today announced updates to its cloud-native data services platform with new capabilities focused on CI/CD acceleration and performance.

Key Points: 
  • NEW YORK, Oct. 26, 2021 /PRNewswire/ --ionir, a leader in Kubernetes Data Services, today announced updates to its cloud-native data services platform with new capabilities focused on CI/CD acceleration and performance.
  • An optimal DevOps environment allows teams to operate and manage infrastructure to develop, test, integrate and deliver Kubernetes hosted applications.
  • Increased performance: ionir now supports a new class of volumes for high performance applications with low latency requirements.
  • ionir is backed by leading international VC funds Jerusalem Venture Partners (JVP) and C5 Capital, among others.

DERMALA, A Consumer Dermatology Company, Announces Issuance of the Second U.S. Patent Covering the Use of Novel Human Microbiome Technology for Treating Acne Vulgaris

Tuesday, October 26, 2021 - 12:00pm

This is the second patent in DERMALA's intellectual property portfolio that covers using the human microbiome to treat and prevent acne.

Key Points: 
  • This is the second patent in DERMALA's intellectual property portfolio that covers using the human microbiome to treat and prevent acne.
  • Acne vulgaris is characterized by microbiome dysbiosis associated with an overgrowth of C. acnes bacteria, followed by inflammation of skin follicles.
  • DERMALA developed a novel technology for enhanced targeted delivery of human microbiome-derived postbiotic metabolites into specific layers of the skin.
  • DERMALA, Inc. is a San Diego-based consumer dermatology company leveraging a scientific understanding of the human microbiome and data analytics to develop novel treatments for chronic skin conditions.

Fintel Announces Issuance of Second U.S. Patent, Strengthening the Company’s Intellectual Property Position in USA PATRIOT Act Section 314(b) Information Sharing Technologies

Tuesday, October 19, 2021 - 8:36pm

11,025,630 entitled, System, method and computer-readable medium for utilizing a shared computer system.

Key Points: 
  • 11,025,630 entitled, System, method and computer-readable medium for utilizing a shared computer system.
  • The patent is directed to systems and methods for financial institutions to securely engage in information sharing under the provisions of the USA PATRIOT Act Section 314(b).
  • Fintels patent portfolio includes two patents granted by the USPTO and two pending applications, all in the area of USA PATRIOT Act 314(b) Information Sharing.
  • Fintel is a financial risk management and compliance software company developing pioneering applications for financial institutions to communicate and share information about financial crimes leveraging USA PATRIOT Act Section 314(b), a government-sanctioned information-sharing program.

Santa Barbara Nutrients' Scientists Awarded Breakthrough Patent Related to Polycystic Kidney Disease

Tuesday, October 19, 2021 - 5:00pm

The patented technology was initially developed by Dr. Weimbs and Dr. Torres at the University of California, Santa Barbara.

Key Points: 
  • The patented technology was initially developed by Dr. Weimbs and Dr. Torres at the University of California, Santa Barbara.
  • SBN has the exclusive worldwide license to commercialize patent claims covering the use of BHB and BHB/citrate in PKD and other renal indications, including chronic kidney disease (CKD) in humans and animals.
  • "We are pleased that the U.S. Patent Office has recognized our unique research in understanding a complex disease like PKD.
  • Santa Barbara Nutrients is a public benefit corporation incorporated in Delaware and headquartered in Santa Barbara, California.

Grant Thornton awarded patent for innovative technology in Whole Ledger Analytics

Tuesday, October 19, 2021 - 3:30pm

Grant Thornton LLP has been awarded a patent by the U.S. Patent and Trademark Office for innovations related to the firms proprietary Whole Ledger Analytics system.

Key Points: 
  • Grant Thornton LLP has been awarded a patent by the U.S. Patent and Trademark Office for innovations related to the firms proprietary Whole Ledger Analytics system.
  • In addition to its patent for Whole Ledger Analytics, Grant Thornton received another U.S. patent in June 2021 for innovations related to the firms controls-test automation app, cta.x .
  • Founded in Chicago in 1924, Grant Thornton LLP (Grant Thornton) is the U.S. member firm of Grant Thornton International Ltd, one of the worlds leading organizations of independent audit, tax and advisory firms.
  • Grant Thornton refers to Grant Thornton LLP, the U.S. member firm of Grant Thornton International Ltd (GTIL).

Santa Barbara Nutrients' Scientists Awarded Breakthrough Patent Related to Polycystic Kidney Disease

Tuesday, October 19, 2021 - 1:37pm

SANTA BARBARA, Calif., Oct. 19, 2021 /PRNewswire/ -- The patented technology was initially developed by Dr. Weimbs and Dr. Torres at the University of California, Santa Barbara.

Key Points: 
  • SANTA BARBARA, Calif., Oct. 19, 2021 /PRNewswire/ -- The patented technology was initially developed by Dr. Weimbs and Dr. Torres at the University of California, Santa Barbara.
  • SBN has the exclusive worldwide license to commercialize patent claims covering the use of BHB and BHB/citrate in PKD and other renal indications, including chronic kidney disease (CKD) in humans and animals.
  • These bioactive ingredients were shown to be effective in preserving kidney structure and function in animal models of PKD.
  • Santa Barbara Nutrients is a public benefit corporationincorporated in Delaware and headquartered in Santa Barbara, California.

Parus Files Second Patent Lawsuit Against Samsung for Infringement of its Proprietary Voice-Browsing and Device Control Technology

Monday, October 18, 2021 - 7:47pm

7,386,455.Parus is seeking all available remedies, including damages against Samsung for all of its infringing sales.

Key Points: 
  • 7,386,455.Parus is seeking all available remedies, including damages against Samsung for all of its infringing sales.
  • The lawsuit asserts that the infringement has been "willful," and requests that the defendant be ordered to pay treble damages and Parus' attorneys' fees, and be permanently enjoined from infringing the Parus Patents.
  • "Parus has a responsibility to its customers and shareholders to protect the investments Parus has made in its innovative technologies.
  • Parus intends to vigorously defend its valuable patent portfolio and other intellectual property," said Taj Reneau, Chairman and CEO.

PURA and PAOG Partner On CBD Lab Construction And Hemp Cultivar Development

Friday, October 15, 2021 - 2:42pm

Dallas, Texas, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) (PURA) and PAO Group, Inc.s (OTC Pink: PAOG) (PAOG) today confirmed PAOGs partnership within PURAs new Farmersville Hemp Brand initiative.

Key Points: 
  • Dallas, Texas, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) (PURA) and PAO Group, Inc.s (OTC Pink: PAOG) (PAOG) today confirmed PAOGs partnership within PURAs new Farmersville Hemp Brand initiative.
  • PURA is building hemp processing and cultivation partnerships with the intention of establishing an industrial hemp brand cooperative under the Farmersville Hemp Brand name.
  • In the fashion that Sun-Maid Raisins collectively markets for growers all selling under one brand name, PURA plans to collectively market for multiple hemp growers and processors under the Farmersville Hemp Brand name.
  • In conjunction with PAOGs ongoing CBD research, PAOG is specifically partnering with PURA in the dosing and construction of a lab and greenhouse for cultivating pharmaceutical grade hemp and developing proprietary hemp cultivars.

PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research

Friday, October 15, 2021 - 2:25pm

Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No.

Key Points: 
  • Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No.
  • The ongoing research targets the treatment of respiratory disorders in support of a pharmaceutical being developed by PAOG under the name RespRx .
  • PAOG's RespRx research has shown effectiveness in the treatment of Chronic Obstructive Pulmonary Disease (COPD)and other similar respiratory conditions.
  • The British Medical Journal (BMJ) today released a report on a case study where CBD demonstrated effectiveness in the treatment of lung cancer and COPD.